Skip to main navigation Home Careers Contact French English SEC FILINGS Investor Relations Investors Press Releases Corporate Governance Stock Market Data SEC Filings AMF Regulated Information Shareholders Meeting Financial calendar Analyst Coverage Webcasts Corporate Presentation SEC Filing Keyword Search Group Filing year - Any - Items per page 10 Filing date Form Description Filing Group View Nov 30, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000046.pdf 0001624422-21-000046.rtf View HTML Nov 16, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000044.pdf 0001624422-21-000044.rtf View HTML Oct 25, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000042.pdf 0001624422-21-000042.rtf View HTML Oct 05, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000040.pdf 0001624422-21-000040.rtf View HTML Sep 29, 2021 EFFECT EFFECT Other 9999999995-21-003704.pdf 9999999995-21-003704.rtf View HTML Sep 21, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000039.pdf 0001624422-21-000039.rtf View HTML Sep 21, 2021 F-3 Registration statement for certain foreign private issuers offered for certain transactions Registration Statements 0001193125-21-278075.pdf 0001193125-21-278075.rtf View HTML Sep 20, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000037.pdf 0001624422-21-000037.rtf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Jul 30, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000033.pdf 0001624422-21-000033.rtf View HTML Jul 26, 2021 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 0001624422-21-000031.pdf 0001624422-21-000031.rtf View HTML Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Displaying 1 - 10 of 123 results All information contained in, and documents linked to, this website are being provided for informational purposes only and to comply with applicable regulations. The information contained in, and documents linked to, this website should not be used or considered as, and do not constitute, an offer to sell or a solicitation of any offer to buy any securities of ERYTECH in any jurisdiction. ERYTECH provides no advice or recommendations with respect to the use of this website, and nothing contained on this website constitutes investment, legal, tax, regulatory or other advice, nor should be relied upon in making an investment or other decision. Print Page RSS Feeds E-mail Alerts IR Contact Erytech PharmaSA 60 Avenue Rockefeller 69008 Lyon France Erytech Pharma Inc. One Main Street Suite 1150 Cambridge, Massachusetts 02142, USA About Us Technology Platform Pipeline Investors Newsroom Contact Copyright © 2021. Erytech Pharma. All rights reserved. Terms & Conditions